Signaling in Cell Damage and Cancer

Our group focuses its research on the study of intracellular and intercellular mechanisms that are activated in response to injury, particularly in liver and neurodegenerative diseases as well as processes of carcinogenesis. Our work combines cell models and primary cultures with animal models that mimic human diseases. The ultimate goal is a better understanding of the signaling involved in diseases allows developing therapeutic interventions to improve the treatment of human disease. The main lines of research we address are: - Therapeutic targets in Alzheimer's disease (Dr. Anna Colell). https://scholar.google.es/citations?user=TfiuS4MAAAAJ&hl=en - Mechanisms in liver inflammation and fibrosis (Dr. Montserrat Marí). https://scholar.google.es/citations?user=JfvWZkIAAAAJ&hl=en - Therapies in hepatocellular damage and cancer (Dr. Albert Morales, Coordinator). https://scholar.google.es/citations?user=aziENiMAAAAJ&hl=en